Stocks
PAREXEL Intl Corp.PRXL
NASDAQHealthcareLife Sciences Tools & Services$88.08-0.02%
A contract research organization providing clinical trial management, regulatory consulting, and commercialization services to pharmaceutical, biotechnology, and medical device companies. Its work supports the design and execution of global drug development programs, making it part of the outsourced...
Market Cap: $052W Range: $51.16 – $88.10
Congressional Interest in PAREXEL Intl Corp. (PRXL)
4 members of Congress have disclosed 16 trades in PAREXEL Intl Corp. (PRXL), a Healthcare company. The buy/sell breakdown shows 7 purchases versus 9 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
16
Unique Politicians
4
Buys
7
Sells
9
Who in Congress Is Trading PRXL?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-08-23 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2017-04-17 | MICHAEL T. MCCAUL | sell | $1K – $15K |